2m 2m 2m 2m 2m 2m 2m
Sarepta Therap (SRPT)
NASDAQ
$15.23+$0.37 (+2.50%)
Price as of Aug 03, 2026 10:20 AM EDT- $1.6BMarket Cap
- -6.60%1-Year Change
- BiotechnologyIndustry
Sarepta Therap (SRPT)
$15.23+$0.37 (+2.50%)
SRPT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.86 | ||
Change | -$0.70 (-4.50%) | ||
Open | $15.50 | ||
High | $15.64 | ||
Low | $14.84 | ||
Previous Close | $15.56 | ||
Volume | 3,603,368 | ||
30-Day Average Volume | 3,181,641 | ||
1-Week Change | -5.23% | ||
1-Month Change | -17.31% | ||
1-Year Change | -6.60% | ||
3-Year Change | -86.29% | ||
5-Year Change | -78.08% | ||
Fundamentals | |||
Shares Outstanding | 105.6M | ||
Total Assets | $3.2B | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $730.8M | ||
Net Income | $331.0M | ||
Free Cash Flow | -$204.8M | ||
EBIT | $364.9M | ||
EBITDA | $375.5M | ||
Net Working Capital | $1.8B | ||
EPS | $2.88 | ||
Enterprise Value/EBITDA | 5 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 1 | ||
P/E | 5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue